Dapagliflozin
D1690L00067
Approved small_molecule completed
Quick answer
Dapagliflozin for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed